Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y
Department of Neuropathology and Neuroscience, Faculty of Pharmaceutical Sciences, Ibaraki, Japan.
Neuron. 1994 Jul;13(1):45-53. doi: 10.1016/0896-6273(94)90458-8.
To learn about the carboxy-terminal extent of amyloid beta-protein (A beta) composition of senile plaques (SPs) in the brain affected with Alzheimer's disease (AD), we employed two end-specific monoclonal antibodies as immunocytochemical probes: one is specific for A beta 40, the carboxyl terminus of A beta 1-40, while the other is specific for A beta 42(43). In the AD cortex, all SPs that were labeled with an authentic antibody were A beta 42(43) positive, while only one-third of which, on the average, were A beta 40 positive. There was a strong correlation between A beta 40 positivity and mature plaques. Two familial AD cortices with the mutation of beta-amyloid protein precursor 717 (beta APP717) (Val to Ile) showed a remarkable predominance of A beta 42(43)-positive, A beta 40-negative plaques. Diffuse plaques, representing the earliest stage of A beta deposition, were exclusively positive for A beta 42(43), but completely negative for A beta 40.
为了解患阿尔茨海默病(AD)大脑中淀粉样β蛋白(Aβ)在老年斑(SPs)中的羧基末端组成情况,我们采用两种末端特异性单克隆抗体作为免疫细胞化学探针:一种对Aβ1-40的羧基末端Aβ40具有特异性,另一种对Aβ42(43)具有特异性。在AD皮质中,所有用正宗抗体标记的SPs均为Aβ42(43)阳性,而平均只有三分之一为Aβ40阳性。Aβ40阳性与成熟斑块之间存在很强的相关性。两个携带β淀粉样蛋白前体717(βAPP717)(缬氨酸突变为异亮氨酸)突变的家族性AD皮质显示,Aβ42(43)阳性、Aβ40阴性的斑块显著占优势。代表Aβ沉积最早阶段的弥漫性斑块仅对Aβ42(43)呈阳性,但对Aβ40完全呈阴性。